SETH SANDESH (CEO) received a stock award from ACTINIUM PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/19/2022ACC: 0001213900-22-049737
DirectorOfficer· CEO
Since Jul 2018
+300K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
300K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+300K
Price / share
—
Trade value
—
% of position
5575.2%
8/17/2022
5.38K→305.38K
Total
Net shares
+300K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/17/2022 | A · Award | +300K | — | — | 5575.2% | 5.38K | 305.38K |
| Total | +300K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported